WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Disease and Therapy Review: Major Depressive Disorder

Timely Data Resources, Inc, September 2012, Pages: 17

The Major Depressive Disorder Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the depression market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.

The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. OVERVIEW
General overview of the condition
Symptoms

II. INCIDENCE AND PREVALENCE
Incidence Table (US, UK, Worldwide)
Prevalence Table (Canada, US, Brazil, Chile, Colombia, Mexico, France, Germany, Italy, Romania, Spain, UK, China, India, Japan, Australia, New Zealand, Europe, Low/Middle Income Countries, High Income Countries, Worldwide)

III. DIAGNOSIS
Common characteristics
DSM-IV Criteria

IV. TREATMENT AND DOSING
Phases of therapy
Drug therapy
Dosing for commonly prescribed drugs
Non-drug therapy

V. TREATMENT COSTS
Costs for commonly prescribed non-generic drugs

VI. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VII. COMMENTS

VIII. REFERENCES/RESOURCES

Customers who bought this item also bought